Mountain View, CA, May 14, 2005
IMPAC
Medical Systems, Inc., part of the Elekta
Group and a leading provider of information technology solutions
for oncology care, and The Mattson Jack Group (MJG), a world
leader in healthcare consulting services, today announce an
expanded licensing agreement that will grant MJG access to
IMPAC’s oncology-specific electronic medical record (EMR) for
point of care data, in addition to data from its National
Oncology DataBase™ (NODB), to be used in MJG’s Patient Metrics
module of Cancer!MPact.
Like the NODB, the EMR data is provided from participating IMPAC
customers. The new de-identified EMR-derived dataset has the
potential for adding a unique and expanded body of information
from hundreds of thousands of cancer cases in near real time.
When added to data from the more than 2 million NODB cancer
registry derived cases, it greatly augments the breadth and
depth of the resultant information.
Bill Mattson, Co-chairman and Co-CEO of the Mattson Jack Group
said, “We are pleased to expand our ongoing relationship with
IMPAC. This agreement will facilitate research and analyses on
geographical trends. The longitudinal EMR point of care data
will be invaluable in providing more timely information on
actual treatment practice at the point of care.
“IMPAC and The Mattson Jack Group have a long history of working
together. We are pleased to expand our agreement so that
retrospective analysis and research into treatment practices and
outcomes can be taken to the next level,” said Joseph K.
Jachinowski, IMPAC president and CEO.
Demonstrations of IMPAC’s oncology-specific EMR will be
available at IMPAC’s booth # 2872 during the annual meeting of
the American Society of Clinical Oncology (ASCO) in Orlando,
Florida, May 14-16, 2005.
********
For more information, please contact:
Julie DeSantis, Public Relations Manager
IMPAC Medical Systems, Inc.
Tel: +1 650-623-8883, e-mail: jdesantis@impac.com
Investor Enquiries:
International: Peter Ejemyr, Group VP Corporate Communications,
Elekta AB
Tel: +46 733 611 000, e-mail: peter.ejemyr@elekta.com
United States: Lars Jonsteg, VP Investor Relations North
America, Elekta Inc.
Tel: +46 708-783 735, e-mail: lars.jonsteg@elekta.com
About IMPAC Medical Systems, Inc.
IMPAC Medical Systems, Inc., a company in the Elekta Group,
provides healthcare IT solutions that streamline clinical and
business operations across the spectrum of cancer care. IMPAC’s
open integration to multiple healthcare data and imaging systems
offers oncology-specific patient charting and practice
management, as well as best-of-breed systems for anatomic
pathology, clinical laboratory, and cancer registry. With
products that range from diagnosis and treatment through
long-term follow-up, IMPAC provides a comprehensive oncology
management solution that helps improve overall communication,
process efficiency, and quality patient care. For more
information about IMPAC’s products or services, please call
888-GO-IMPAC or visit www.impac.com.
About
Elekta
Elekta is an international medical-technology Group, providing
meaningful clinical solutions, comprehensive information systems
and services for improved cancer care and management of brain
disorders. All of Elekta’s solutions employ non-invasive or
minimally invasive techniques and are therefore clinically
effective, gentle on the patient and cost-effective.
With approx. 1700 employees, Elekta’s corporate headquarter is
located in Stockholm, Sweden and the company is listed on the
Stockholm Stock Exchange under the ticker EKTAb. For more
information about Elekta’s products or services, please visit
www.elekta.com.
About the
Mattson Jack Group
Formed in 1986, MJG focuses its talent in three areas of core
competency: Business Analytics, Brand Optimization and Corporate
Development Services in the pharmaceutical and biotech markets.
Its ongoing mission is to “Accelerate Client Growth through
advanced analysis, planning, decision support, and
implementation.” MJG consultants have expertise in pricing and
reimbursement, custom epidemiology, technology assessment,
business and strategic plan development, due-diligence and
licensing support, market modeling and forecasting, and primary
market research. The Mattson Jack Group is a member of the
Kantar Division of WPP Company, a $6.5 billion global
communications services firm. For more information, please visit
www.mattsonjack.com.
|
